The medical community as a whole is aware that patients show variable respo
nses to drug treatments but physicians currently lack efficient tools to pr
edict these drug responses and to select appropriate treatments. Coupling o
ur knowledge of genetic polymorphisms with clinical-response data promises
a bright future for rapid advances in personalized medicine.